Autoimmune Disease Diagnostics Market – By Product (Reagents, Instruments), By Disease Type (Systemic, Localized), By Test Type (Antinuclear Antibody Tests, Autoantibody Tests, C-reactive Protein, Urinalysis), By End-use (Hospitals, Diagnostic Centers) – Global Forecast, 2024 – 2032
Report ID: GMI618
|
Published Date: September 2024
|
Report Format: PDF
Download free sample
Get a free sample of Autoimmune Disease Diagnostics Market
Get a free sample of Autoimmune Disease Diagnostics Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 12
Tables & Figures: 234
Countries covered: 24
Pages: 190
Download Free Sample
Autoimmune Disease Diagnostics Market Size
Autoimmune Disease Diagnostics Market size was valued at USD 5.3 billion in 2023 and is anticipated to witness growth at a CAGR of 5.9% between 2024 and 2032. The rising incidence of autoimmune diseases and the adoption of automation in equipment are vital factors propelling global market growth.
Autoimmune disorders develop when the immune system mistakenly attacks its own cells due to abnormalities. A failure to detect immune cells, tissues, and organs, coupled with the production of autoantibodies targeting these cells, causes the immune system to malfunction. Consequently, several initiatives by organizations aim to raise awareness about autoimmune diseases and their socioeconomic impact, thereby increasing the usage rates of autoimmune disease diagnostics globally. Additionally, improved laboratory automation and technological advancements in diagnostics are driving the expansion of the autoimmune disease diagnostics market.
Autoimmune diseases are conditions where the immune system attacks one or more normally functioning cells in the body due to asymmetry or irregularities. This malfunction is primarily caused by the immune system's inability to recognize tissues, immunological cells, and other organs, leading to the production of autoantibodies against these cells.
However, the need for high capital investment in setting up diagnostic centers, slow turnaround times for test results, and the requirement for multiple diagnostic tests can adversely affect market growth. Diagnostic centers for autoimmune diseases face stringent government regulations and diagnostic complications that may negatively impact business expansion. Various blood tests, such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), enzyme-linked immunosorbent assay (ELISA), and rheumatoid factor (RF), are used to detect the type and severity of autoimmune diseases.
Autoimmune Disease Diagnostics Market Trends
The substantial surge in the number of patients affected by autoimmune diseases is among the major factors propelling market growth in the foreseeable future. Type 1 diabetes, rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are some of the most common conditions that require autoimmune diagnostics and treatment.
Autoimmune Disease Diagnostics Market Analysis
The market, by product, is bifurcated into reagents and consumables, and instruments. The reagents and consumables segment dominated the market with a revenue of around USD 3.5 billion in 2023.
The autoimmune disease diagnostics market by disease type, is bifurcated into systemic autoimmune disease and localized autoimmune disease. The localized autoimmune disease segment dominated the market with a revenue of around USD 3.7 billion in 2023 and is expected to grow at a CAGR of 5.7%.
Based on test type, the autoimmune disease diagnostics market is segmented into antinuclear antibody tests, autoantibody tests, c-reactive protein (CRP), complete blood count (CBC), urinalysis, and other tests. The antinuclear antibody tests segment was valued at over USD 2.3 billion in 2023 and is anticipated to grow at a 6.1% CAGR from 2024-2032.
By end-use, the autoimmune disease diagnostics market is segmented into hospitals, diagnostic centers, and other end-users. The hospitals segment accounted for a majority market share of 53.5% in 2023 and is expected to proliferate the market growth during the analysis period. This significant market share is owing to the surged adoption of autoimmune disease diagnostic procedures in hospitals associated to complex interventional surgeries.
North America autoimmune disease diagnostics market accounted for USD 1.9 billion in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
Autoimmune Disease Diagnostics Market Share
The global market is highly competitive, characterized by rapid advancements in diagnostic technologies and a growing focus on early detection. Market players are continuously innovating to improve the accuracy, efficiency, and accessibility of diagnostic tests. The landscape is shaped by frequent product launches, strategic partnerships, and mergers and acquisitions aimed at expanding market presence. Additionally, increased investment in research and development, along with rising awareness of autoimmune diseases, is driving competition. The market is also influenced by regional expansions and the adoption of automation in diagnostic processes, further intensifying the competitive environment.
Autoimmune Disease Diagnostics Market Companies
Some of the eminent market participants operating in the autoimmune disease diagnostics industry include:
Autoimmune Disease Diagnostics Industry News:
The autoimmune disease diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Disease Type
Market, By Test Type
Market, By End-use
The above information is provided for the following regions and countries: